Metcela Company
Metcela provides regenerative medicine for treatment of Ischemic Heart Disease.
Technology:
Regenerative Medicine
Industry:
Biotechnology, Health Care, Medical
Headquarters:
Japan
Founded Date:
2016-03-09
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
10
Total Funding:
950000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
43971
Last Funding Type:
Series B
Register and Claim Ownership